Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head

Stem Cell Research and Therapy

Volumn 3, Issue 1, 2012, Pages

  Rackwitz, Lars ^a   Eden, Lars ^a   Reppenhagen, Stephan ^a   Reichert, Johannes C ^a   Jakob, Franz ^a   Walles, Heike ^a   Pullig, Oliver ^a   Tuan, Rocky S ^b   Rudert, Maximilian ^a   Nöth, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 14; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCATTER FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; SIGNAL PEPTIDE; VASCULOTROPIN A;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANGIOGENESIS; ANTEROGRADE OSTEOCHONDRAL RECONSTRUCTION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS CHONDROCYTE IMPLANTATION; AVASCULAR NECROSIS; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE GRAFT; BONE PLATE; BONE REGENERATION; BONE REMODELING; BONE STRUCTURE; CHONDROCYTE IMPLANTATION; DISEASE SEVERITY; FEMUR HEAD NECROSIS; HUMAN; MATRIX BASED AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOSAICPLASTY; NONHUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; CYTOLOGY;

BONE MORPHOGENETIC PROTEINS; FEMUR HEAD NECROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; STEM CELL FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857462043     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt98     Document Type: Review

References (61)

1. Non-traumatic avascular necrosis of the femoral head. Mont MA, Hungerford DS, J Bone Joint Surg Am 1995 77 459 474 7890797
2. The incidence of osteonecrosis. Vail TP, Covington DB, Osteonecrosis: Etiology, Diagnosis, Treatment Rosemont, IL: American Academy of Orthopedic Surgeons, Urbaniak JR, Jones JR, 1997 43 49
3. Osteonecrosis of the hip: management in the 21st century. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR, Instr Course Lect 2003 52 337 355 12690862
4. Cell delivery therapeutics for musculoskeletal regeneration. Nöth U, Rackwitz L, Steinert AF, Tuan RS, Adv Drug Deliv Rev 2010 62 765 783 10.1016/j.addr.2010.04.004 20398712
5. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Baksh D, Song L, Tuan RS, J Cell Mol Med 2004 8 301 316 10.1111/j.1582-4934.2004.tb00320.x 15491506 (Pubitemid 44145494)
6. Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. Yan Z, Hang D, Guo C, Chen Z, J Orthop Res 2009 27 442 446 10.1002/jor.20759 18925660
7. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
8. Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction. Brunt KR, Hall SR, Ward CA, Melo LG, Methods Mol Med 2007 139 197 210 10.1007/978-1-59745-571-8-12 18287673
9. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Feng Y, Yang SH, Xiao BJ, Xu WH, Ye SN, Xia T, Zheng D, Liu XZ, Liao YF, Bone 2010 46 32 40 10.1016/j.bone.2009.09.001 19747991
10. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM, J Am Coll Cardiol 2004 44 1690 1699 10.1016/j.jacc.2004.08.014 15489105 (Pubitemid 39369805)
11. Treatment of osteonecrosis with autologous bone marrow grafting. Hernigou P, Beaujean F, Clin Orthop Relat Res 2002 405 14 23 12461352 (Pubitemid 36008240)
12. Core decompression with marrow stem cells. Hernigou P, Manicom O, Poignard A, Nogier A, Filippini P, De Abreu L, Operative Tech Orthop 2004 14 68 74 10.1053/j.oto.2004.03.001 (Pubitemid 39060748)
13. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H, J Bone Joint Surg Br 2005 87 896 902 (Pubitemid 40984256)
14. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique. Gangji V, Hauzeur JP, J Bone Joint Surg Am 2005 87 106 112 (Pubitemid 40315042)
15. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study. Gangji V, De Maertelaer V, Hauzeur JP, Bone 2011 49 1005 1009 10.1016/j.bone.2011.07.032 21821156
16. Challenges with advanced therapy medicinal products and how to meet them. Committee for Advanced Therapies (CAT); CAT Scientific Secretariat, Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Ancns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, et al. Nat Rev Drug Discov 2010 9 195 201 10.1038/nrd3052 20190786
17. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis. Müller I, Vaegler M, Holzwarth C, Tzaribatchev N, Pfister SM, Schütt B, Reize P, Greil J, Handgretinger R, Rudert M, Leukemia 2008 22 2054 2061 10.1038/leu.2008.217 18719618
18. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Kawate K, Yajima H, Ohgushi H, Kotobuki N, Sugimoto K, Ohmura T, Kobata Y, Shigematsu K, Kawamura K, Tamai K, Takakura Y, Artif Organs 2006 30 960 962 10.1111/j.1525-1594.2006.00333.x 17181837 (Pubitemid 44915585)
19. A quantitative system for staging avascular necrosis. Steinberg ME, Hayken GD, Steinberg DR, J Bone Joint Surg Br 1995 77 34 41 7822393
20. Cell based therapy for the treatment of femoral head necrosis. Nöth U, Reichert J, Reppenhagen S, Steinert A, Rackwitz L, Eulert J, Beckmann J, Tingart M, Orthopade 2007 36 466 471 10.1007/s00132-007-1087-2 17479247 (Pubitemid 46895883)
21. VascuBone homepage. http://www.vascubone.fraunhofer.eu
22. Immunological aspects of allogeneic mesenchymal stem cell therapies. Griffin MD, Ritter T, Mahon BP, Hum Gene Ther 2010 21 1641 1655 10.1089/hum.2010.156 20718666
23. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK, Nat Med 1999 5 309 313 10.1038/6529 10086387 (Pubitemid 29124367)
24. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T, Proc Natl Acad Sci USA 2002 99 8932 8937 10.1073/pnas. 132252399 12084934 (Pubitemid 34693661)
25. Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration. Reddi AH, Ann Rheum Dis 2003 62 i73 ii78
26. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. Tsumaki N, Tanaka K, Arikawa-Hirasawa E, Nakase T, Kimura T, Thomas JT, Ochi T, Luyten FP, Yamada Y, J Cell Biol 1999 144 161 173 10.1083/jcb.144.1.161 9885252 (Pubitemid 29047019)
27. Stimulatory effects of cartilage-derived morphogenetic proteins 1 and 2 on osteogenic differentiation of bone marrow stromal cells. Gruber R, Mayer C, Schulz W, Graninger W, Peterlik M, Watzek G, Luyten FP, Erlacher L, Cytokine 2000 12 1630 1638 10.1006/cyto.2000.0760 11052813
28. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH, Clin Orthop Relat Res 1998 355 314 S335
29. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Lieberman JR, Conduah A, Urist MR, Clin Orthop Relat Res 2004 429 139 145 15577478 (Pubitemid 39579204)
30. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Mont MA, Etienne G, Ragland PS, Clin Orthop Relat Res 2003 417 84 92 14646705 (Pubitemid 37499513)
31. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Seyler TM, Marker DR, Ulrich SD, Fatscher T, Mont MA, Clin Orthop Relat Res 2008 466 1125 1132 10.1007/s11999-008-0211-x 18351424
32. Strutautografting with and without osteogenic protein-1: a preliminary study of a canine femoral head defect model. Mont MA, Jones LC, Elias JJ, Inoue N, Yoon TR, Chao EY, Hungerford DS, J Bone Joint Surg Am 2001 83 1013 1022 11451970 (Pubitemid 32662103)
33. Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model. Simank HG, Manggold J, Sebald W, Ries R, Richter W, Ewerbeck V, Sergi C, Growth Factors 2001 19 247 257 10.3109/08977190109001090 11811780 (Pubitemid 34071671)
34. Growth and differentiation factor 5 (GDF-5) composite improves the healing of necrosis of the femoral head in a sheep model. Analysis of an animal model. Simank HG, Herold F, Schneider M, Maedler U, Ries R, Sergi C, Orthopade 2004 33 68 75 10.1007/s00132-003-0541-z 14747913 (Pubitemid 38198576)
35. Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. Tang TT, Lu B, Yue B, Xie XH, Xie YZ, Dai KR, Lu JX, Lou JR, J Bone Joint Surg Br 2007 89 127 129 17259431
36. Vascular endothelial growth factor: basic science and clinical progress. Ferrara N, Endocr Rev 2004 25 581 611 10.1210/er.2003-0027 15294883 (Pubitemid 39099316)
37. Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit. Yang C, Yang S, Du J, Li J, Xu W, Xiong Y, Chin Med J 2003 116 1544 1548 14570620 (Pubitemid 37461676)
38. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Toth ZE, Leker RR, Shahar T, Pastorino S, Szalayova I, Asemenew B, Key S, Parmelee A, Mayer B, Nemeth K, Bratincsák A, Mezey E, Blood 2008 111 5544 5552 10.1182/blood-2007-10- 119073 18268092
39. A combination of granulocyte colony-stimulating factor and stem cell factor ameliorates steroid-associated osteonecrosis in rabbits. Wu X, Yang S, Duan D, Liu X, Zhang Y, Wang J, Yang C, Jiang S, J Rheumatol 2008 35 2241 2248 10.3899/jrheum.071209 18792998
40. Hepatocytes and scatter factor. Gherardi E, Stoker M, Nature 1990 346 228 2142751 (Pubitemid 20227395)
41. Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Wen Q, Ma L, Chen YP, Yang L, Luo W, Wang XN, Gene Ther 2008 15 1523 1535 10.1038/gt.2008.110 18633448
42. The trapdoor procedure using autogenous cortical and cancellous bone grafts for osteonecrosis of the femoral head. Mont MA, Einhorn TA, Sponseller PD, Hungerford DS, J Bone Joint Surg Br 1998 80 56 62 10.1302/0301-620X.80B1. 7989 9460954 (Pubitemid 28048490)
43. Advances in hip arthroplasty in the treatment of osteonecrosis. Seyler TM, Cui Q, Mihalko WM, Mont MA, Saleh KJ, Instr Course Lect 2007 56 221 233 17472309
44. Surgical dislocation of the adult hip a technique with full access to the femoral head and acetabulum without the risk of avascular necrosis. Ganz R, Gill TJ, Gautier E, Ganz K, Krügel N, Berlemann U, J Bone Joint Surg Br 2001 83 1119 1124 10.1302/0301-620X.83B8.11964 11764423
45. Fresh autogenous grafts and osteochondral allografts for the treatment of segmental collapse in osteonecrosis of the hip. Meyers MH, Jones RE, Bucholz RW, Wenger DR, Clin Orthop Relat Res 1983 174 107 112 6339133 (Pubitemid 13122178)
46. Resurfacing of the femoral head with fresh osteochondral allografts. Long-term results. Meyers MH, Clin Orthop Relat Res 1985 197 111 114 3893823 (Pubitemid 15018922)
47. Autogenous osteochondral transfer in the femoral head after osteonecrosis. Sotereanos NG, DeMeo PJ, Hughes TB, Bargiotas K, Wohlrab D, Orthopedics 2008 31 177 19292191
48. Five-year results following autogenous osteochondral transplantation to the femoral head. Rittmeister M, Hochmuth K, Kriener S, Richolt J, Orthopade 2005 34 320 326 10.1007/s00132-005-0776-y 15726318 (Pubitemid 40718738)
49. Autologous chondrocyte implantation with bone grafting for osteochondral defect due to posttraumatic osteonecrosis of the hip-a case report. Akimau P, Bhosale A, Harrison PE, Roberts S, McCall IW, Richardson JB, Ashton BA, Acta Orthop 2006 77 333 336 10.1080/17453670610046208 16752299
50. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Brittberg M, Am J Sports Med 2010 38 1259 1271
51. A prospective multicenter study on the outcome of type I collagen hydrogel-based ACI (CaReS) for the repair of articular cartilage defects in the knee. Schneider U, Rackwitz L, Andereya S, Siebenlist S, Fensky F, Reichert J, Löer I, Barthel T, Rudert M, Nöth U, Am J Sports Med 2011 39 2558 2565 10.1177/0363546511423369 21984690
52. Microfracture: surgical technique and rehabilitation to treat chondral defects. Steadman JR, Rodkey WG, Rodrigo JJ, Clin Orthop Relat Res 2001 391 362 S369
53. Mid-term results of Autologous Matrix Induced Chondrogenesis for treatment of focal cartilage defects in the knee. Gille J, Schuseil E, Wimmer J, Gellissen J, Schulz AP, Behrens P, Knee Surg Sports Traumatol Arthrosc 2010 18 1456 1464 10.1007/s00167-010-1042-3 20127072
54. Future strategies in the treatment of avascular necrosis of the femoral head [in German]. Nöth U, Reppenhagen S, Steinert A, Jakob F, Reichert J, Rudert M, Rackwitz L, Osteologie 2010 19 53 59
55. Classification systems for osteonecrosis: an overview. Steinberg ME, Steinberg DR, Orthop Clin North Am 2004 35 273 283 10.1016/j.ocl.2004.02.005 15271535 (Pubitemid 38953962)
56. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. Ficat RP, J Bone Joint Surg Br 1985 67 3 9 3155745 (Pubitemid 15037534)
57. Long-term results of core decompression for ischaemic necrosis of the femoral head. Fairbank AC, Bhatia D, Jinnah RH, Hungerford DS, J Bone Joint Surg Br 1995 77 42 49 7822394
58. Core decompression versus nonoperative management for osteonecrosis of the hip. Mont MA, Carbone JJ, Fairbank AC, Clin Orthop 1996 324 169 178 8595753 (Pubitemid 26071763)
59. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH, J Bone Joint Surg Br 1995 77 870 874 7593097
60. Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head. Chen CC, Lin CL, Chen WC, Shih HN, Ueng SW, Lee MS, J Bone Joint Surg Am 2009 91 2390 2394 10.2106/JBJS.H.01814 19797574
61. Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head. McGrory BJ, York SC, Iorio R, Macaulay W, Pelker RR, Parsely BS, Teeny SM, J Bone Joint Surg Am 2007 89 1194 1204 10.2106/JBJS.F.00302 17545421 (Pubitemid 46897989)